Gerardo Guillén Selected Research

Recombinant Fusion Proteins

7/2012	Serotype specificity of recombinant fusion protein containing domain III and capsid protein of dengue virus 2.
6/2011	The two component adjuvant IC31® potentiates the protective immunity induced by a dengue 2 recombinant fusion protein in mice.
12/2008	Serotype-specificity of recombinant fusion proteins containing domain III of dengue virus.
1/2008	Anamnestic antibody response after viral challenge in monkeys immunized with dengue 2 recombinant fusion proteins.
4/2006	A recombinant fusion protein containing the domain III of the dengue-2 envelope protein is immunogenic and protective in nonhuman primates.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gerardo Guillén Research Topics

Disease

28	Dengue (Dengue Fever) 01/2016 - 08/2003
10	Infections 06/2017 - 01/2008
5	Viremia 01/2019 - 08/2003
3	COVID-19 01/2022 - 02/2021
3	Neoplasms (Cancer) 02/2021 - 12/2005
3	Virus Diseases (Viral Diseases) 06/2017 - 02/2010
2	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 01/2008
2	Viral Encephalitis 01/2016 - 04/2009
2	Encephalitis (Encephalitis, Rasmussen) 01/2016 - 01/2013
2	Necrosis 06/2012 - 02/2007
1	Pneumonia (Pneumonitis) 02/2021
1	Severe Dengue 01/2019
1	Hepatitis B 01/2018
1	Reinfection 06/2017
1	Meningococcal Infections 02/2010
1	Breast Neoplasms (Breast Cancer) 01/2008
1	Body Weight (Weight, Body) 02/2007
1	Coronary Occlusion 02/2007
1	Myocardial Infarction 02/2007
1	Diabetic Foot 09/2006
1	Wounds and Injuries (Trauma) 09/2006
1	Ulcer 09/2006
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2005

Drug/Important Bio-Agent (IBA)

24	VaccinesIBA 01/2022 - 08/2003
21	Proteins (Proteins, Gene)FDA Link 12/2021 - 08/2003
9	Neutralizing AntibodiesIBA 01/2019 - 08/2003
9	Capsid Proteins (Capsid Protein)IBA 06/2017 - 01/2007
7	Recombinant ProteinsIBA 07/2014 - 01/2008
6	AntibodiesIBA 01/2019 - 08/2003
5	Antiviral Agents (Antivirals)IBA 06/2017 - 01/2007
5	Recombinant Fusion ProteinsIBA 07/2012 - 04/2006
4	Dengue VaccinesIBA 07/2014 - 04/2009
3	Carrier Proteins (Binding Protein)IBA 06/2011 - 02/2009
2	Peptides (Polypeptides)IBA 02/2021 - 12/2005
2	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2019 - 01/2008
2	AntigensIBA 01/2016 - 01/2013
2	Interferon-gamma (Interferon, gamma)IBA 07/2014 - 06/2012
2	Combined VaccinesIBA 07/2014 - 06/2012
2	Viral AntigensIBA 07/2012 - 12/2008
2	EpitopesIBA 07/2012 - 12/2008
2	Immunoglobulin M (IgM)IBA 01/2008 - 08/2003
2	Amino Acids FDA Link 10/2006 - 01/2004
1	Subunit VaccinesIBA 12/2021
1	Protein Kinases (Protein Kinase)IBA 02/2021
1	Testosterone (Sustanon)FDA Link 01/2019
1	OligodeoxyribonucleotidesIBA 01/2015
1	aluminum sulfate (alum)IBA 01/2015
1	Interferon Type IIBA 07/2014
1	Immunoglobulin G (IgG)IBA 07/2012
1	CytokinesIBA 06/2012
1	Polysaccharides (Glycans)IBA 05/2012
1	Indicators and Reagents (Reagents)IBA 12/2009
1	Hormones (Hormone)IBA 01/2008
1	AndrogensIBA 01/2008
1	gamma- aminobutyryl- 2- methyltryptophyl- 2- methyltryptophyl- 2- methyltryptophyl- lysinamideIBA 02/2007
1	Oxidants (Oxidizing Agents)IBA 02/2007
1	Saline SolutionIBA 02/2007
1	Epidermal Growth Factor (EGF)IBA 09/2006
1	Glycoproteins (Glycoprotein)IBA 08/2003

Therapy/Procedure

1	Therapeutics 01/2019
1	Surgical Amputation (Amputations) 09/2006
1	Immunotherapy 12/2005